(Q42641490)

4 November 2017

Pharmacokinetics of bumetanide in critically ill infants (English)

1 reference

4 November 2017

1 reference

5

Blumer JL

1 reference

4 November 2017

4

Myers CM

1 reference

4 November 2017

Sullivan JE

1

1 reference

4 November 2017

Witte MK

series ordinal

2

1 reference

4 November 2017

Yamashita TS

series ordinal

3

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

Clinical Pharmacology & Therapeutics

4 November 2017

1 reference

4 November 2017

60

1 reference

4 November 2017

4

1 reference

4 November 2017

405-413

1 reference

Comparison of Adverse Reactions to Bumetanide and Furosemide

4 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Bumetanide and frusemide: a comparison of dose-response curves in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Pathogenesis and treatment of edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Diuretic therapeutics in the pediatric patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Bumetanide: Potent New "Loop" Diuretic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Pharmacokinetics of diuretics and methylxanthines in the neonate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Protein binding and bilirubin displacing properties of bumetanide and furosemide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Pharmacokinetics and pharmacodynamics of bumetanide in neonates treated with extracorporeal membrane oxygenation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Contribution of American pediatricians to treatment of diarrheal dehydration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Kinetics, dynamics, and bioavailability of bumetanide in healthy subjects and patients with chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Diuretic effect and metabolism of bumetanide in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Pharmacokinetics of bumetanide following intravenous, intramuscular, and oral administrations to normal subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Kinetics, dynamics, and bioavailability of bumetanide in healthy subjects and patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Pharmacokinetics of furosemide in neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Pharmacology of furosemide in the premature newborn infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Pharmacokinetic disposition and protein binding of furosemide in newborn infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Plasma and urinary kinetics of furosemide in newborn infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Bumetanide in heart failure in infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Letter: Frusemide, bumetanide, and ototoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

Comparative acute ototoxicity of intravenous bumetanide and furosemide in the pure-bred beagle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990197-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9236(96)90197-6

1 reference

4 November 2017

1 reference